ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib. - Piotrowska Z; Ahn MJ; Voon PJ; Pang YK; How SH; Kim SW; Cortinovis D; de Castro Carpeño J; Tiseo M; Rodríguez Abreu D; Ramalingam SS; Li J; et al. (Cancer discovery, 2026)